SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Earnings History & Surprises

FRA:1SXP • DE000A3ENQ51

13.92 EUR
-0.06 (-0.43%)
Last: Mar 9, 2026, 05:29 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

Past quarterly earnings results for SCHOTT PHARMA AG& CO KGAA (1SXP.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateMay 13, 2026
PeriodQ2 / 2026
EPS Estimate€0.24
Revenue Estimate255.07M

Last Reported

Most Recent
Release DateFeb 11, 2026
PeriodQ1 / 2026
EPS Reported
EPS Surprise %
Revenue Surprise 2.64%

Beat Rate

Last 8 Quarters
19%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (EUR)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q1 2026 0.20 - 7.77% 240.188M 234.02M 2.64% 4.50%
Q4 2025 0.22 0.23 -3.50% - 247.583M 252.62M -1.99% 4.44%
Q3 2025 0.30 0.30 -1.05% -3.23% 256.46M 262.43M -2.27% 1.13%
Q2 2025 0.26 0.25 5.48% 52.94% 252.326M 247.99M 1.75% 7.95%
Q1 2025 0.19 0.22 -14.42% -34.48% 229.841M 242.74M -5.31% -1.04%
Q4 2024 0.22 0.25 -10.99% -4.35% 237.051M 244.39M -3.00% 3.73%
Q3 2024 0.31 0.21 50.83% - 253.587M 228.25M 11.10% -62.16%
Q2 2024 0.17 0.21 -20.63% - 233.749M 238.89M -2.15% -
Q1 2024 0.29 0.28 3.11% - 232.251M 212M 9.55% -
Q4 2023 0.23 0.16 40.93% - 228.516M 233.12M -1.97% 12.57%
Q3 2023 - - 670.086M - 8.41%
Q4 2022 - - 203M - -
Q3 2022 - - 618.108M - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

1SXP.DE EPS Q2Q Growth1SXP.DE EPS Q2Q GrowthEPS Q2Q Growth Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Q3/26 Q4/26 0 20 -20 40

Revenue Historical Q2Q growth and Acceleration

1SXP.DE Revenue Q2Q Growth1SXP.DE Revenue Q2Q GrowthRevenue Q2Q Growth Q3/23 Q4/23 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Q3/26 Q4/26 0 -20 -40 -60

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
2
Average Revenue beat (4)
0.03%
Max Revenue beat (4)
2.64%
Min Revenue beat (4)
-2.27%

Analysis

1SXP.DE has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, 1SXP.DE has beaten the revenue estimates by 0.0% on average.

Related analysis

1SXP.DE Overview 1SXP.DE Technical Analysis Report 1SXP.DE Fundamental Analysis Report 1SXP.DE Forecast & Price Target
 → Find peers who consistently beat earnings by at least 10% in the last 4 quarters

SCHOTT PHARMA AG& CO KGAA / 1SXP.DE Earnings FAQ

Can you provide the last earnings date for SCHOTT PHARMA AG& CO KGAA?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) last reported earnings on 2/11/2026.


Did 1SXP stock beat earnings estimates in the most recent quarter?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) missed EPS estimates and beat revenue estimates in the most recent quarter.